Table 2.
Treatment of CFS | Lactobacillus strains | Diameter of inhibition zone (cm) | |||
---|---|---|---|---|---|
L. monocytogenes ATCC® 19111™ | S. aureus 3048 | E. coli 3014 | S. Typhimurium FP1 | ||
Before treatment | Lb. plantarum SF9C | 1.92 ± 0.03az | 1.57 ± 0.06ay | 1.50 ± 0.05ayw | 1.38 ± 0.03aw |
Lb. brevis SF9B | 0.00 ± 0.00ez | 0.00 ± 0.00ez | 0.00 ± 0.00ez | 0.00 ± 0.00fz | |
Combined SF9C + SF9B | 1.72 ± 0.03bz | 0.98 ± 0.03dx | 1.13 ± 0.06cy | 1.00 ± 0.00cx | |
proteinase K | Lb. plantarum SF9C | 1.10 ± 0.00dy | 1.17 ± 0.03cyz | 1.23 ± 0.03bz | 1.20 ± 0.00bxz |
Lb. brevis SF9B | 0.00 ± 0.00ez | 0.00 ± 0.00ez | 0.00 ± 0.00ez | 0.00 ± 0.00fz | |
Combined SF9C + SF9B | 1.02 ± 0.03dz | 0.90 ± 0.00dy | 0.98 ± 0.03dz | 0.85 ± 0.00ey | |
100 °C/30 min | Lb. plantarum SF9C | 1.68 ± 0.03bz | 1.52 ± 0.03by | 1.30 ± 0.00bx | 1.23 ± 0.03bx |
Lb. brevis SF9B | 0.00 ± 0.00ez | 0.00 ± 0.00ez | 0.00 ± 0.00ez | 0.00 ± 0.00fz | |
Combined SF9C + SF9B | 1.53 ± 0.06cz | 0.93 ± 0.06dx | 1.03 ± 0.06cdy | 0.92 ± 0.03dx |
abcdefDifferent letter means statistically significant difference (p < 0.05) within the same column among the treatments of CFSs and used Lactobacillus strains
wxyzDifferent letter means statistically significant difference (p < 0.05) within the same row among the used pathogens. Statistical analysis was carried out using ANOVA and the results are reported as mean value ± SD of three independent experiments